Camphor toxicity: Difference between revisions
(clin features) |
(clinical features) |
||
| Line 9: | Line 9: | ||
*Vertigo, confusion, agitation | *Vertigo, confusion, agitation | ||
*Seizure, respiratory depression, coma | *Seizure, respiratory depression, coma | ||
*Hepatitis and liver failure | |||
==References== | ==References== | ||
Revision as of 02:05, 22 January 2016
Background
- Common topical agent for pain relief, wart removal, osteoarthritis, cold sores
- FDA limits over the counter preparations to 11%[1]
- Highly lipophilic, widely and rapidly distributed, symptom onset 5-15 minutes
Clinical Features
- Nausea, vomiting, abdominal pain
- Oral burning, headache
- Vertigo, confusion, agitation
- Seizure, respiratory depression, coma
- Hepatitis and liver failure
References
- ↑ United States Food and Drug Administration. Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph. Fed Reg 1983